Special Interests: Acute Leukaemia, Multiple Myeloma, Stem Cell Transplantation (incl cord-blood / haplo-identical donor), Immune Effector Cells. Dr Eleni Tholouli graduated in Germany and completed her haematology specialist training in Manchester where she also undertook a PhD at Manchester University investigating prognostic molecular markers in acute myeloid leukaemia. She then consolidated her transplant experience as a Transplant Fellow at the Fred Hutchinson Research Cancer Centre in Seattle, USA, one of the world’s largest stem cell transplant centres. She is the Director of the Adult Stem Cell Transplant and Cellular/Gene Therapy unit at Manchester Royal Infirmary. Her expertise covers a wide range of haemato-oncological malignancies (leukaemia, myeloma, lymphoma) and non-malignant disorders (bone marrow failures, aplastic anaemia). She is a member of the UK AML Research Network and has authored and co-authored many publications including manuscripts and book chapters and presented at many scientific national and international congresses.

I am currently working as an Immunoglobulin Clinical Nurse Specialist and serve as a member of the East of England Immunoglobulin Assessment Panel at Cambridge University Hospitals NHS Foundation Trust. This is a unique and evolving role in which I act as the Regional Clinical Specialist Nurse for Immunology across the East of England, supporting initiatives to enhance the quality of care for patients with primary and secondary immunodeficiencies throughout the region.The post supports direct patient care, immunoglobulin (Ig) home therapy training, and the development of patient pathways across multiple specialties. This includes close collaboration with neurology services supporting patients with peripheral nerve disorders, as well as haematology-oncology teams to ensure effective, and patient-centred immunoglobulin therapy delivery. As a Nurse Assessor for QPID – Quality in Primary Immunodeficiencies this role provides an invaluable opportunity to contribute to this vital accreditation programme, supporting services nationally to strengthen standards and continuously improve care for individuals living with primary and secondary antibody immunodeficiency disorders, as well as haematology-oncology teams to ensure effective, and patient-centred immunoglobulin therapy delivery.

Honorary Clinical Associate Professor, Institute of Infection, Immunity and Transplantation- University College London (Chair) David Lowe is a Consultant Immunologist at the Royal Free Hospital in London and Principal Investigator at the Institute of Infection, Immunity and Transplantation at UCL. He trained in Infectious Diseases and General Internal Medicine and completed an Immunology PhD, mainly looking at neutrophils. He now manages a large cohort of patients with primary and secondary immunodeficiency. His main research interests are in the prevention and management of infection in immunocompromised patients.